Form D · Biotechnology

PiroGon, Inc.

North Haven, CT · CIK 0001913179

Offering snapshot reported Mar 12, 2024 · SEC filing

Reported sold
$1.34M
Offering amount: $1.34M
Investors reported
25
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jan 20, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$668K$1.34MMay 17, 2022: $990,000.00May 17, 2022Mar 12, 2024: $1,335,000.00Mar 12, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$990,000 → $1,335,000
  • Reported investors21 → 25

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 12, 2024Amendment$1,335,000$345,000vs May 17, 202225SEC filing
May 17, 2022Initial$990,000No comparison21SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-445977

Source: Form D, filed Mar 12, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Pramod Bonde Director
Rigu Gupta Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
154 State Street, Suite 106
North Haven, CT, 06473